AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JUN 12 - (NewsRx.com & NewsRx.net) -- May 18, 2002 marked the Fifth Annual HIV Vaccine Awareness Day, which highlighted research advances and the challenges of the HIV/AIDS pandemic, and underscored why developing preventive HIV vaccines offers the best hope for controlling the AIDS pandemic.
Thousands of volunteers worldwide who have participated in studies to test candidate HIV vaccines were recognized. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health has been supporting HIV vaccine studies since 1987.
"HIV vaccine research is our best hope, along with other prevention efforts, to slow the spread of HIV," said NIAID Director Anthony S. Fauci, MD "May 18th [provided] us with an opportunity to recognize the researchers, community educators, and thousands of volunteers around the world who have been involved in the quest for an HIV vaccine."
Increased federal funding has expanded the HIV vaccine pipeline by allowing for more exploration of various vaccine strategies. During the past 6 years, six potential HIV vaccines were tested in 12 small-scale clinical trials conducted both in the U.S. and around the world. Over the next two years, more than a dozen potential vaccines are expected to be ready for testing, requiring more than 20 clinical trials of various sizes. This investment in vaccine research has made the discovery of an effective HIV vaccine more possible today than ever before.
"The public ...